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EDITORIAL SPECIAL COLLECTION: TRANSLATIONAL IMPACT OF RAT
A RATional choice for translational research?
Tim Aitman1,*, Paraminder Dhillon2 and Aron M. Geurts3,*
ABSTRACT
Future prospects continue to be strong for research using the rat as a
model organism.New technologyhasenabled theproliferationofmany
new transgenic and knockout rat strains, the genomes of more than 40
rat strains have been sequenced, publications using the rat as a model
continue to be produced at a steady rate, and discoveries of disease-
associated genes and mechanisms from rat experiments abound,
frequently with conservation of function between rats and humans.
However, advances in genome technology have led to increasing
insights into human disease directly from human genetic studies,
pulling more andmore researchers into the human genetics arena and
placing funding for model organisms and their databases under threat.
This, therefore, is a pivotal time for rat-based biomedical research – a
timely moment to review progress and prospects – providing the
inspiration for a new Special Collection focused on the impact of the
model on translational science, launched in this issue of Disease
Models & Mechanisms. What disease areas are most appropriate for
research using rats? Why should the rat be favoured over other model
organisms, and should the present levels of funding be continued?
Which approaches shouldwe expect to yield biologically andmedically
useful insights in the coming years? These are key issues that are
addressed in the original Research Articles and reviews published in
this Special Collection, and in this introductory Editorial. These
exemplar articles serve as a landmark for the present status quo
after a decade ofmajor advances using the rat model and could help to
guide the direction of rat research in the coming decade.
KEY WORDS: CRISPR, Genomics, Model organism, Rat,
Translational
Putting the ‘rat’ in laboratory
The rat is one of the premier models for studies of physiology,
pharmacology, toxicology and neurobehaviour, reflected by an
immense literature heritage. Over 1.5 million PubMed entries
include the terms ‘Rattus norvegicus’; almost as many as for all
other model organisms combined. Although there have been more
publications on the mouse in the last decade, publications using the
rat model continue to be strong (Fig. 1) and, as foretold in an
Editorial introducing a Nature Genetics issue focused on rat
genetics in 2008, “Although the mouse is still the mammalian
genetic model of choice, the gap may be closing” (Editorial, 2008).
Eight years on from those heady days, how does the landscape lie?
Oneway of assessing the strength of a model system is to consider
the techniques and infrastructure available for its study. Another
measure of a model’s ‘success’, particularly relevant to studies of
human disease, is its applicability to human physiology and
pathophysiology. Relevant to the availability of tools, the first rat
genome was sequenced in 2004 – it was the third mammalian
genome sequence ever to have been completed. Over 40 rat
genomes have been sequenced since that time, including 27
genomes for which an evolutionary analysis defined the
phylogenetic history and selection pressures underlying derivation
of 11 widely used models of hypertension and diabetes (Atanur
et al., 2013). Although initially lagging behind the mouse and other
model organisms in terms of gene-targeting technologies, the rat
was the first mammal in which zinc-finger nucleases (ZFNs) were
used by embryo microinjection to create a gene knockout (Geurts
et al., 2009). Since then, in just one centre alone – the Genome
Editing Rat Resource Center (GERRC) at the Medical College of
Wisconsin (MCW) – around 200 rat gene knockout, knock-in,
conditional, transgenic and Cre-recombinase driver lines have been
created or are at various stages of development for distribution to the
research community (http://rgd.mcw.edu/rgdweb/models/gerrc.
html). Over 200 additional transgenic or gene mutants have been
created in other centres, including 15 in the European Union (EU)-
funded ELABORATE programme based in Edinburgh. Two major
rat model repositories, the Rat Resource & Research Center (http://
www.rrrc.us) in Missouri and the National Bio Resource Project –
Rat in Kyoto, Japan (http://www.anim.med.kyoto-u.ac.jp/NBR/)
provide the community with options for long-term preservation and
distribution of these models.
Without doubt, the rat remains a keymodel for basic and preclinical
studies of pharmacology and toxicology, underlining its importance
in studies of human disease. A PubMed search usingMedical Subject
Headings (MeSH) terms (Pharmacology) OR (Toxicology) AND rat,
mouse or other model organisms, revealed 6230 articles for rat, 7495
for mouse and less than 1000 combined for fly, zebrafish, worm and
yeast, between January 2000 and August 2016. For physiological
studies, the rat has the advantage of size – and therefore ease and
precision of measurements – over the mouse, although higher
maintenance costs for rats and the opportunities of probe
miniaturisation and imaging have offset these advantages to some
extent in recent years. For neurobehaviour, compared to other model
systems, the larger forebrain size and greater sophistication and
sociability of the rat continue to provide more power and
comparability with humans (Ellenbroek and Youn, 2016).
However, research funding is increasingly competitive for model
organism communities. Throughout the 1990s and 2000s, major
funds provided by theNational Institutes ofHealth (NIH) and the EU
drove the sequencing of the first rat genome and, supported by the
EU consortia EURATools and EURATRANS, the development of
genome tools and databases led to a host of gene discoveries, many
of which were translated to human disease (Aitman et al., 2008).
Although the discovery of disease genes and mechanisms has
continued, the rat community has been under increasing pressure in
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recent years. No concerted EU-derived funding of rat research
followed the EURATRANS programme, and NIH funding for
model organism databases, including the outstanding Rat Genome
Database (RGD; described below), which is funded only until 2018,
is potentially under threat. However, a recent petition in support of
model organism databases gained over 11,000 signatures and
generated a positive response from the NIH that recognises the need
for continuing support. More recently, global uncertainty in the rat
genetics community resulted in the unexpected cancellation of an
international meeting that has been running annually for more than
15 years – the Rat Genomes and Models meeting. This meeting,
which rotated betweenCold SpringHarbor Laboratory inNewYork,
USA, the Wellcome Trust Sanger Institute in Hinxton, UK, and
Kyoto, Japan, represented a key opportunity for networking and
collaboration within the rat genetics community. In the Model for
Life interview published in this issue, Howard Jacob discusses the
impact that the early years of this meeting had on the rat genetics
field and beyond (Jacob, 2016).
Notwithstanding these challenges, the rat model research
community remains active and enthusiastic, the quality of
ongoing research remains high, and publication rates remain
steady (Fig. 1). High-profile research groups across the world and
strong ongoing programmes for generating rat knockouts (NIH
GERRC and EU ELABORATE) take advantage of the genome-
editing tools and technologies now in place to use the rat model as a
springboard for giving insights into human disease (Zhao et al.,
2015; Fernandez-Duenas et al., 2015; Wang et al., 2016). In this
issue of Disease Models & Mechanisms (DMM), we are pleased to
launch a timely Special Collection entitled Spotlight on Rat:
Translational Impact, which highlights the strengths and ongoing
commitment of researchers and funders to studies of the rat model
for generating insights into mechanisms underlying human disease.
This issue is fully compiled of articles (research, reviews and others)
focused on the use of rats for translational research, and further
articles will be added to the collection in upcoming issues of the
journal. The collection page (http://dmm.biologists.org/collection/
rat-disease-model) also features some of the most impactful rat-
based articles published in DMM in recent years.
Frontrunners: reviews and more
Kicking off the review section of the issue, Howard Jacob, pioneer
in the rat genetics community, provides a retrospective view of
the field in an exclusive interview. Describing his path from
pharmacology student to leader of a clinical genomics centre for
paediatric patients, Howard explains why he firmly believes that the
rat – as well as other model organisms – has a key role to play in this
era of genomic medicine (Jacob, 2016).
Among other contributions to the rat genetics and genomics
toolbox during his years at MCW, Howard played a central part in
the establishment of RGD in 1999. Since then, the database has
evolved into the leading resource to obtain genetic, genomic,
phenotype and disease-relevant rat data and to make comparisons
with corresponding human and mouse data. In a Special Article also
published in this issue,Mary Shimoyama and other curators of RGD
describe –with worked examples – how the impressive suite of tools
and datasets can be used to leverage rat studies to provide new
insights into disease pathways and genetics (Shimoyama et al.,
2016).
Despite initially trailing behind the mouse in the availability of
tools and technologies for generating recombinant models – a topic
that will be discussed in depth by Aron Geurts and Tomoji Mashimo
in an upcoming DMM Review article – the rat has always been
at the forefront as a model in genome-wide mapping studies. As
highlighted by Aida Moreno-Moral and Enrico Petretto in the
first of three new Reviews published in this issue, the first fully
‘integrative’ genomics study was performed in rats (Moreno-Moral
and Petretto, 2016). The availability of specialised inbred
strains and large panels for genetic mapping meant that several
additional integrative-genomics (and, more recently, ‘systems-
genetics’) studies exploiting the model to link genotype with
phenotype then followed. This has resulted in advances in our
understanding of the genetics of many complex human conditions,
ranging from hypertension to alcohol addiction. Indeed, systems-
genetics analysis of rats was used to shed light on diet-induced
obesity in a new research study published in this issue (Martínez-
Micaelo et al., 2016; described further below).
Gene-mapping strategies in rat models have also led to a
better understanding of the genetic underpinnings of rheumatoid
arthritis. A second Review in this issue, contributed by Anthony
Yau and Rikard Holmdahl, describes arthritis-associated genetic
polymorphisms that have been identified by genetic linkage and
positional cloning using rat congenic strains (Yau and Holmdahl,
2016). The authors provide examples to illustrate how exploration of
arthritis-linked polymorphisms using rats has provided new insights
that are relevant to clinical autoimmune arthritis.
A research area in which rats have truly shone as a model system
is in neuroscience. Bart Ellenbroek and Jiun Youn provide a broad
overview of the utility and advantages of rats in neuroscientific
studies in their At a Glance poster article (Ellenbroek and
Youn, 2016). The authors discuss how fundamental differences
between rats and mice result in substantially different outcomes
in a variety of neurobehavioural tests and impact on studies of
neurodegeneration. While emphasising the unique advantages and
limitations associated with each species, they provide an argument
for rats being the better model for exploring neuropsychiatric traits.
A related Review published previously in DMM critically appraises
rat-based insights into the biological basis of addictive behaviour
(Jupp et al., 2013).
The final Review in this issue, by Jacob Kjell and Lars Olson,
highlights the tremendous progress that has been made in
understanding and treating spinal cord injuries based on rat
research (Kjell and Olson, 2016). From enabling a picture of the
pathological events involved in different forms of spinal cord injury
to be built, to facilitating the evaluation of repair strategies, the rat








Fig. 1. Trends in model organism publications (2005-2015). Model
organism papers published between 2005 and 2015, as revealed by querying
National Center for Biotechnology Information (NCBI) PubMed using the
indicated species as search terms.
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has provided a key experimental model for this area of research for
many years, and is poised to continue to enable bench-to-bedside
advances.
Original research contributions: the uniqueness of the rat
model
Also showcased in this issue are ten original research articles that
serve as paradigms of the ways in which the rat stands as a
distinctive model system across diverse areas, including
neuroscience and neurobehaviour, musculoskeletal disease,
oncology, metabolism, and infection and immunity.
In the first of four research articles relevant to the neuroscience and
neurobehaviour field, Judith Homberg and colleagues studied a rat
strain with an N-ethyl-N-nitrosourea (ENU) mutagenesis-induced
dysfunctionalDrd1dopamine receptorwith decreased transmembrane
insertion (Homberg et al., 2016). The mutant strain displayed a deficit
in several aspects of social cognition, providing much-needed
clarification of the neurobehavioral function of this receptor where
previous analysis ofDrd1 knockoutmice had given rise to inconsistent
findings. In another contribution from the Ellenbroek group, exposure
to lipopolysaccharide (LPS) in pregnant rats was used to mimic the
known effects ofmaternal infection and inflammation that impair fetal
brain development, predispose to cognitive deficits and, in humans,
increase the riskof schizophrenia. The team tested the hypothesis that a
high incidence of smoking in schizophrenics might be due to the
putative cognitive-enhancing effects of nicotine. In support of this
effect, the authors found that global cognitive deficits induced by early
LPS exposurewere at least in part reversed by nicotine treatment in the
offspring (Waterhouse et al., 2016).
Two new studies combined elements of neuroscience and
pharmaco/toxicology. Using a model of excitotoxically induced
vestibular dysfunction based on transtympanic injection of kainic
acid (a neuroexcitatory molecule), Sophie Gaboyard-Niay and
colleagues found that vestibular dysfunction occurred shortly after
excitotoxic insult, and that recovery correlated closely with changes
in the structure and ultrastructure of vestibular hair cells and afferent
nerve terminals (Gaboyard-Niay et al., 2016). This model could
provide a useful platform to investigate the mechanisms of
spontaneous repair of vestibular afferent terminals and to test
regenerative therapies. In the second study, Rong-Kung Tsai and co-
authors aimed to determine the therapeutic window and anti-
inflammatory mechanism for the neuroprotective effect of
granulocyte colony-stimulating factor (G-CSF), using an
established rat model of acute ischemic optic neuropathy. They
showed that early treatment with G-CSF rescued visual function and
retinal ganglion cell survival, most likely through stabilising the
blood–brain barrier and reducing macrophage infiltration (Wen
et al., 2016).
Emphasising the value of the close synteny of the rat and human
genomes, Jayleen Grams and colleagues studied bone biomechanics
in an osteocalcin-null rat created using CRISPR/Cas9 gene
technology (technique illustrated in Ellenbroek and Youn, 2016).
Because the osteocalcin locus has undergone triplication in the
mouse genome, the rat, which, like humans, has a single osteocalcin
gene, has the potential to be more relevant for studies of human
osteocalcin gene variation. Osteocalcin knockout rats demonstrated
increased trabecular thickness and improved functional quality
under biomechanical stress, suggesting new therapeutic approaches
for osteoporosis and osteoarthritis (Lambert et al., 2016).
A new Tp53 mutant rat, created by transferring a mutant Tp53
allele from an outbred genetic background to the inbred F344 strain,
is described in this issue by Elizabeth Bryda, James Amos-Landgraf
and colleagues (Hansen et al., 2016). The team report that the
mutant shows a distinctive tumour spectrum, the primary tumour
types being osteosarcomas and meningeal sarcomas, similar to the
early bone and central nervous system (CNS) sarcomas found in
humans with Tp53 mutations, but not commonly found in mouse
Tp53 mutants. Such commonality with human cancer phenotypes
has previously been seen in the Apc mutant Pirc rat, with intestinal
tumour distribution more typical of human intestinal tumours than
Apc mutant mice (Irving et al., 2014), and in the hormonal
responsiveness of rat breast cancer models (Samuelson et al., 2007).
This study gives further credence to the translational validity of rat
models of human cancer and fills an important gap by providing a
new animal model for the study of paediatric osteosarcomas.
Rats have also been widely used in studies of metabolic disease,
not least because of their many physiological parallels with humans.
In a systems-genetics study of peripheral blood monocytes in rats on
a cafeteria-fed diet, Jacques Behmoaras and colleagues identified a
cluster of genes – with the acyl-CoA synthetase gene Acss2 at its
hub – that underlies differences between rat strains in their
metabolic responses to obesity (Martínez-Micaelo et al., 2016).
Furthermore, Susan Ozanne et al. identified and characterised an
accelerated aging and oxidative-stress phenotype in the skeletal
muscle of offspring of low-protein-fed dams, suggesting that
postnatal antioxidant intervention could reduce the increased risk of
diabetes and cardiovascular disease in individuals exposed in utero
to maternal malnutrition (Tarry-Adkins et al., 2016). Earlier this
year, the Ozanne lab used rats to provide evidence that a serotonin-
mediated mechanism underlies the developmental programming of
obesity (Martin-Gronert et al., 2016).
The biology of hepatitis E infection is poorly understood,
warranting the generation and characterisation of robust animal
models of the infection. Now, Johan Neyts and colleagues have
developed a new model of hepatitis E infection in the athymic nude
rat (Debing et al., 2016). Given the paucity of models in other
species and the increasing recognition of problems with hepatitis E
infection in transplantation, this model is likely to prove valuable for
further understanding of hepatitis E infection and antiviral studies.
Finally, Robert Weissert and colleagues studied gene expression
from CNS-infiltrating cells in the well-established myelin-
oligodendrocyte-glycoprotein-induced experimental autoimmune
encephalomyelitis (EAE) rat model of multiple sclerosis (Herrmann
et al., 2016). The conclusion that Cd38 is involved in the
development of EAE in this model was supported by comparative
experiments in the Cd38 knockout mouse.
Concluding remarks
As demonstrated by the research and reviews published in this issue,
and the hugely positive response to our ‘call for papers’, with
submissions coming in from excellent groups around the world, the
rat model continues to be a leading model for studies of physiology,
pharmacology, toxicology and neuroscience. The reasons for
this are clear – the close evolutionary and genomic relationship
to humans, the sophistication and sociability of the species, the
ease of physiological and behavioural measurements, the huge
heritage collection of genetic, genomic and other biological data,
and the continuing strong publications of important findings
relevant to the understanding of human disease. Notwithstanding
the pull of human genetics and the struggle for concerted funding
for community activities, including meetings and databases, this
Special Collection highlights that rat research is driven by a forward-
looking community, dedicated to increasing our understanding of
basic biology and human disease.
1071


















Traditional quantitative trait locus studies, with the need for
lengthy fine-mapping and testing of candidate genes, continue to
give valuable insights (for example Zhao et al., 2015; Fernandez-
Duenas et al., 2015; Wang et al., 2016, and reviewed in Yau and
Holmdahl, 2016), but, as with research using other model
organisms, these approaches are being replaced by gene targeting
using CRISPR/Cas9 and other techniques, as exemplified by the
GERRC programme (rgd.mcw.edu/wg/gerrc) and the osteocalcin
study in this issue (Lambert et al., 2016). These programmes use
gene targeting to knock out genes implicated in the aetiology of
common human diseases via genome-wide association studies
(GWAS) or other patient-based studies, and allow analysis of gene
function that will give insights into disease pathogenesis.
The present challenges for cohesiveness of the rat genetics
community stand to be overcome by the substantial body of
researchers who recognise the natural advantages of the rat as a
model of human disease, as outlined above, and as a model system
for testing new drug therapies. The underlying paradigm, that
strategic advances in disease prevention and therapy most naturally
arise from a deep understanding of disease pathogenesis, make it
likely that the rat model will remain one of the two most widely used
species for biomedical and pharmaceutical research in the next
decade and beyond.
This article is part of a special subject collection ‘Spotlight on Rat: Translational
Impact’, guest edited by Tim Aitman and Aron Geurts. See related articles in this
collection at http://dmm.biologists.org/collection/rat-disease-model.
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